MG
MYOK

Michael Gelband’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Michael Gelband’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,835
Closed -$371K – 2429
2020
Q2 		$371K Buy
+3,835
New +$320K 0.01% 1213

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Michael Gelband's MYOK Position: Q3 2020 in Review

Michael Gelband sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 3,835 shares — an estimated $371K sold.

Michael Gelband first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $371K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Michael Gelband reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Michael Gelband sold 3,835 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $371K.
  • Michael Gelband first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Michael Gelband's MyoKardia, Inc. Common Stock position peaked at $371K in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.